+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Continuous Peripheral Nerve Block (CPNB) Catheters - Global Strategic Business Report

  • PDF Icon

    Report

  • 93 Pages
  • October 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302887
The global market for Continuous Peripheral Nerve Block (cPNB) Catheters was estimated at US$547.5 Million in 2023 and is projected to reach US$798.5 Million by 2030, growing at a CAGR of 5.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Continuous Peripheral Nerve Block (cPNB) Catheters Market - Key Trends & Drivers Summarized

What Are Continuous Peripheral Nerve Block (cPNB) Catheters, and Why Are They Important in Pain Management?

Continuous Peripheral Nerve Block (cPNB) catheters are medical devices used to deliver local anesthetics directly to peripheral nerves, providing targeted and continuous pain relief for patients undergoing surgery or managing chronic pain. Unlike traditional pain management techniques that may rely on opioids, cPNB catheters offer a localized approach, minimizing the risk of systemic side effects and reducing the need for narcotic pain medications. Typically placed by anesthesiologists, these catheters allow for the controlled infusion of anesthetic agents, providing pain relief that can last from days to weeks, depending on the patient's needs. cPNB catheters are particularly valuable in postoperative pain management, as they enable patients to recover with less discomfort, supporting quicker mobilization and reducing the risk of complications related to prolonged bed rest.

The importance of cPNB catheters has grown in response to the opioid crisis, as healthcare providers seek safer, effective alternatives for pain management. For procedures such as orthopedic surgeries (e.g., knee, hip, and shoulder replacements), continuous nerve blocks are associated with improved pain control and reduced opioid consumption, helping patients recover more comfortably and with fewer side effects. Additionally, cPNB catheters are beneficial in ambulatory and outpatient settings, as they offer prolonged analgesia without the need for hospital stays, allowing patients to return home with a catheter that provides ongoing pain relief. This method of pain management is thus transforming the landscape of perioperative care, offering a precise and personalized approach that prioritizes patient comfort and minimizes opioid dependency risks.

How Are Technological Advancements Enhancing the Efficacy and Safety of cPNB Catheters?

Technological advancements are significantly improving the efficacy, safety, and usability of cPNB catheters, making them more accessible for a broader range of patients and procedures. Innovations in catheter design, materials, and ultrasound-guided placement techniques have enhanced the precision and effectiveness of nerve blocks. For instance, modern cPNB catheters are often made with flexible, kink-resistant materials that are less likely to dislodge, providing continuous analgesia with minimal complications. Ultrasound guidance has revolutionized the placement of cPNB catheters, allowing anesthesiologists to visualize the needle and catheter in real time, improving accuracy and reducing the risk of nerve damage or other complications. This approach also minimizes the amount of anesthetic required, enhancing patient safety by reducing potential toxicity.

In addition to ultrasound, electronic infusion pumps are being used in tandem with cPNB catheters to ensure consistent, controlled delivery of anesthetic. These programmable devices can be customized to deliver specific doses at set intervals, allowing for precise pain control that aligns with patient needs. Some pumps are even equipped with wireless connectivity, enabling remote monitoring by healthcare providers, who can adjust infusion rates if necessary, adding a layer of oversight for patients receiving care at home. Furthermore, antimicrobial-coated catheters and improvements in catheter securement techniques have helped to reduce infection risks, making cPNB catheters a safer option for long-term pain management. Together, these technological innovations support the broader adoption of cPNB catheters by enhancing both their effectiveness and safety, ultimately benefiting patients and healthcare providers alike.

Where Are cPNB Catheters Primarily Used, and How Is Demand Evolving?

cPNB catheters are primarily used in surgical settings for postoperative pain management, especially in orthopedic and trauma surgeries, where long-term pain relief is essential for recovery. In orthopedic surgeries, such as total joint replacements and ACL repairs, cPNB catheters provide targeted analgesia that can last throughout the initial recovery period, minimizing pain during critical stages of rehabilitation. Their use has become standard in many orthopedic practices, as they allow patients to start physical therapy sooner and with less discomfort, potentially reducing hospital stays and improving functional outcomes. The use of cPNB catheters is also growing in ambulatory surgery centers, where patients undergo outpatient procedures and can return home the same day with a catheter in place to manage their postoperative pain.

Demand for cPNB catheters is rising as healthcare providers prioritize multimodal and opioid-sparing pain management approaches. The ongoing opioid crisis has heightened the need for non-opioid options, and cPNB catheters have proven effective in achieving substantial pain relief without the risks associated with opioids. Additionally, cPNB catheters are increasingly used in palliative care and chronic pain management, offering an alternative for patients with conditions such as cancer pain or chronic regional pain syndrome. As awareness of cPNB's benefits grows among healthcare providers and patients, demand is expected to increase, particularly in outpatient settings where patients require effective pain management without hospitalization. This trend aligns with a broader shift in healthcare toward patient-centered, minimally invasive treatment options that enhance recovery and reduce healthcare costs.

What Factors Drive the cPNB Catheter Market's Growth?

The growth in the continuous peripheral nerve block (cPNB) catheter market is driven by multiple factors, including the shift toward non-opioid pain management, advancements in catheter and pump technology, and the expanding range of applications for cPNB. The rising prevalence of orthopedic surgeries, such as knee and hip replacements, is a significant driver, as these procedures often require long-lasting pain control to support rehabilitation. In response to the opioid crisis, healthcare providers and patients alike are increasingly seeking opioid-sparing options, and cPNB catheters provide effective analgesia without the risks associated with narcotic use. This trend is particularly strong in countries with stringent regulations on opioid prescribing, where cPNB catheters offer a safe, reliable alternative for managing both acute and chronic pain.

Technological advancements, such as ultrasound-guided placement, electronic infusion pumps, and antimicrobial coatings, are enhancing the safety and usability of cPNB catheters, further supporting market growth. These innovations make it easier for providers to place and manage the catheters effectively, ensuring optimal pain relief with fewer complications. Additionally, the rise of ambulatory and outpatient surgical centers, where patients are discharged the same day, has fueled demand for cPNB catheters, as they allow patients to manage pain at home safely and effectively. Finally, the expanding use of cPNB catheters in palliative care and chronic pain management has opened new applications for this technology, underscoring its versatility and effectiveness in various clinical settings. Together, these drivers are shaping a robust market outlook for cPNB catheters as a critical tool in modern pain management practices.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Ultrasound Insertion Technique segment, which is expected to reach US$385.1 Million by 2030 with a CAGR of a 5.9%. The Nerve Stimulation Insertion Technique segment is also set to grow at 5.1% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $145.2 Million in 2023, and China, forecasted to grow at an impressive 8.4% CAGR to reach $179.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Continuous Peripheral Nerve Block (cPNB) Catheters Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Continuous Peripheral Nerve Block (cPNB) Catheters Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Continuous Peripheral Nerve Block (cPNB) Catheters Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Continuous Peripheral Nerve Block (CPNB) Catheters market such as Ace Medical, B. Braun Melsungen AG, Epimed International, Halyard Health, Inc., PAJUNK GmbH and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 42 companies featured in this Continuous Peripheral Nerve Block (CPNB) Catheters market report include:

  • Ace Medical
  • B. Braun Melsungen AG
  • Epimed International
  • Halyard Health, Inc.
  • PAJUNK GmbH
  • Teleflex Incorporated
  • Vygon

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Continuous Peripheral Nerve Block (cPNB) Catheters - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Postoperative Pain Management Needs Drives Demand for Continuous Peripheral Nerve Block (cPNB) Catheters
  • Shift Toward Opioid-Sparing Pain Management Alternatives Expands Market for cPNB Catheters in Surgical Applications
  • Technological Advancements in Ultrasound-Guided Placement Propel Growth of Precision-Based cPNB Catheter Techniques
  • Increased Focus on Patient-Centered Care and Comfort Supports Adoption of cPNB Catheters for Minimally Invasive Pain Relief
  • Expansion of Ambulatory Surgery Centers (ASCs) Drives Demand for Portable, Long-Lasting cPNB Catheters for Outpatient Procedures
  • Growing Demand for Post-Surgical Pain Relief in Orthopedic Procedures Spurs Use of cPNB Catheters in Knee and Hip Replacements
  • Increased Awareness of Enhanced Recovery After Surgery (ERAS) Protocols Expands Market for cPNB Catheters in Perioperative Care
  • Development of Patient-Controlled Analgesia (PCA) Pumps with cPNB Integration Improves Customization of Pain Management
  • Growth of Regional Anesthesia Techniques Drives Adoption of cPNB Catheters in Complex and High-Risk Surgical Procedures
  • Advancements in Biocompatible and Antimicrobial Catheter Materials Enhance Safety and Durability of cPNB Catheters
  • Increased Application in Palliative Care Settings Expands Demand for cPNB Catheters for Chronic and Cancer Pain Management
  • Rising Focus on At-Home Care Solutions and Patient Mobility Fuels Market for Portable cPNB Catheter Systems
  • Increased Utilization of cPNB Catheters in Military and Trauma Care Settings Drives Demand for Field-Compatible Pain Solutions
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Continuous Peripheral Nerve Block (cPNB) Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Continuous Peripheral Nerve Block (cPNB) Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Continuous Peripheral Nerve Block (cPNB) Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Both by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Both by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Both by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Lower Extremity Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Lower Extremity Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Lower Extremity Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Upper Extremity Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Upper Extremity Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Upper Extremity Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 22: World Continuous Peripheral Nerve Block (cPNB) Catheters Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Continuous Peripheral Nerve Block (cPNB) Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
CANADA
JAPAN
  • Continuous Peripheral Nerve Block (cPNB) Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Continuous Peripheral Nerve Block (cPNB) Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Continuous Peripheral Nerve Block (cPNB) Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
  • Continuous Peripheral Nerve Block (cPNB) Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Continuous Peripheral Nerve Block (cPNB) Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Continuous Peripheral Nerve Block (cPNB) Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Continuous Peripheral Nerve Block (cPNB) Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
AUSTRALIA
  • Continuous Peripheral Nerve Block (cPNB) Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Continuous Peripheral Nerve Block (cPNB) Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Continuous Peripheral Nerve Block (cPNB) Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Continuous Peripheral Nerve Block (cPNB) Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Continuous Peripheral Nerve Block (cPNB) Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ace Medical
  • B. Braun Melsungen AG
  • Epimed International
  • Halyard Health, Inc.
  • PAJUNK GmbH
  • Teleflex Incorporated
  • Vygon

Table Information